Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risks and benefits for patients with relapsed or refractory diffuse large B-cell lymphoma in early-phase clinical trials: a systematic review and meta-analysis.

The Lancet. Haematology·2026
Same author

Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.

Journal of hematology & oncology·2026
Same author

Bone Marrow Pathology in Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia: A Study of 56 Cases.

European journal of haematology·2026
Same author

Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study.

Haematologica·2026
Same author

Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

Blood advances·2026
Same author

The intersection between transgender identity and migrant background: Experienced barriers and facilitators to healthcare in The Netherlands.

International journal of transgender health·2026

Related Experiment Video

Updated: Aug 15, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K

Mapping hematologists' HIV testing behavior among lymphoma patients-A mixed-methods study.

Saskia Bogers1,2,3, Hanne Zimmermann4,5, Amie Ndong1

  • 1Amsterdam UMC, Location University of Amsterdam, Internal Medicine, Amsterdam, the Netherlands.

Plos One
|January 3, 2023
PubMed
Summary

HIV testing for patients with malignant lymphoma (PWML) is inconsistent. Improving testing requires updated guidelines, electronic reminders, and increased awareness to ensure timely diagnosis and care.

More Related Videos

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.4K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K

Related Experiment Videos

Last Updated: Aug 15, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.4K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K

Area of Science:

  • Oncology
  • Infectious Diseases
  • Public Health

Background:

  • HIV testing rates among patients with malignant lymphoma (PWML) vary significantly.
  • Hematologists' testing behaviors and influencing factors require evaluation for improved implementation.

Purpose of the Study:

  • To assess HIV testing prevalence among PWML in Amsterdam.
  • To identify factors influencing hematologists' HIV testing practices.
  • To explore opportunities for enhancing HIV testing strategies in lymphoma care.

Main Methods:

  • A mixed-methods study combining retrospective data analysis (Jan 2015-June 2020) and prospective surveys/interviews.
  • Analysis of HIV testing rates and positivity in 1,612 PWML.
  • Questionnaires and semi-structured interviews with hematologists and guideline authors.

Main Results:

  • 70% of newly diagnosed and 54% of known lymphoma patients were tested for HIV.
  • HIV positivity rate was 0.7%, exceeding the cost-effectiveness threshold.
  • Hematologists reported varied testing strategies; 85% intended to test PWML.

Conclusions:

  • Significant missed opportunities for HIV testing among PWML exist.
  • Inconsistent testing strategies among hematologists necessitate standardized approaches.
  • Improving HIV testing requires multifaceted interventions, including guideline updates and system support.